Fingerprint
Dive into the research topics of 'Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer
Erika S. Dahl, Raquel Buj, Kelly E. Leon, Jordan M. Newell, Yuka Imamura, Benjamin G. Bitler, Nathaniel W. Snyder, Katherine M. Aird
- Department of Pathology and Laboratory Medicine
- Division of Anatomic Pathology
- Department of Pharmacology
- Department of Biochemistry and Molecular Biology
- Department of Cellular and Molecular Physiology
- Penn State Cancer Institute
- Cancer Institute, Mechanisms of Carcinogenesis
- Department of Obstetrics and Gynecology
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations